title: Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review.
abstract: Geographic atrophy (GA) and choroidal neovascularization (CNV), the two late forms of age-related macular degeneration, are generally considered two distinct entities. However, GA and CNV can occur simultaneously in the same eye, with GA usually occurring first. The prevalence of this combined entity is higher in histological studies than in clinical studies. No distinct systemic or genetic risk characteristics are associated with the combined GA/CNV entity, although on clinical examination and retinal imaging it can feature drusen or subretinal drusenoid deposits. GA and CNV may exist within the spectrum of a single disease, or they may be two very different diseases. Therapy with antivascular endothelial growth factor (anti-VEGF) is often successful for CNV, but some evidence suggests increased rates of GA development in eyes treated with anti-VEGF. In this article, we review the current literature regarding the epidemiology, clinical presentation, and treatment options for patients with the combined GA/CNV entity.
authors.affiliation: Department of Ophthalmology, New York University School of Medicine, New York, N.Y., USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Kaszubski
authors.forename: Tal
authors.initials: T
authors.lastname: Ben Ami
authors.forename: Celine
authors.initials: C
authors.lastname: Saade
authors.forename: R Theodore
authors.initials: RT
authors.lastname: Smith
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015897:Comorbidity; D057092:Geographic Atrophy / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D015995:Prevalence; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D042442:Vascular Endothelial Growth Factors